Bloomberg Intelligence cover image

SpaceX Said to File Confidentially for IPO Before AI Rivals

Bloomberg Intelligence

00:00

Biogen's Appelius acquisition fit

Sam Fezzelli describes Biogen's purchase of Appelius and its strategy shift toward immunology and rare diseases.

Play episode from 14:53
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app